Managing Director of New Ventures - Cedars-Sinai

What the firm says Managing Director, New Ventures Redesign Health + Cedars-Sinai Digital Innovation Platform ABOUT THE COMPANY: Redesign Health https://www.redesignhealth.com/ is a global venture and applied technology firm focused on building next-generation healthcare companies. We manage venture capital and venture buyout strategies, each powered by an AI operating system and team of leading technologists, entrepreneurs, and investors. Our venture capital strategy backs exceptional founders at the earliest stage—often before an idea is fully formed—and provides first institutional capital and an unmatched degree of strategic leverage and domain expertise through exit. Our venture buyout strategy partners with proven management teams through control investments and delivers outsized value by rewiring core products and workflows with AI. Since inception in 2018, Redesign and our portfolio companies have touched the lives of more than 15 million patients, raised over $1.5 billion from premier institutional, sovereign, and strategic investors, and built distinctive partnerships with marquee healthcare organizations and senior leaders around the world. Redesign is based in New York and has offices in Bengaluru, Los Angeles, and Riyadh. ABOUT THE ROLE: Most healthcare investors wait for companies to come to them. This role creates them. Redesign Health and Cedars-Sinai have launched a Digital Innovation Platform, a first-of-its-kind venture creation engine embedded inside one of the world’s premier academic medical centers. The platform combines Redesign’s healthcare company-building methodology with something no standalone venture firm can offer: Cedars-Sinai’s 4,500+ physicians and nurses, its expansive clinical network of 40+ hospitals and sites of care, a purpose-buil

公司怎么说 新 ventures 董事总经理 Redesign Health + Cedars-Sinai 数字创新平台 关于公司：Redesign Health https://www.redesignhealth.com/ 是一家全球风险投资和应用技术公司，专注于打造下一代医疗健康公司。我们管理风险投资和风险并购策略，二者均由 AI 操作系统以及一支由领先技术专家、企业家和投资者组成的团队驱动。我们的风险投资策略在最早阶段支持卓越创始人——往往是在想法尚未完全成形之前——并提供首笔机构资本以及无与伦比的战略杠杆和领域专业知识，直至退出。我们的风险并购策略通过控制性投资与经过验证的管理团队合作，并通过用 AI 重构核心产品和工作流程来创造超额价值。自 2018 年成立以来，Redesign 及我们的投资组合公司已触达超过 1500 万名患者的生活，从顶级机构、主权和战略投资者处筹集了超过 15 亿美元，并与全球知名医疗健康组织和高级领导者建立了独特的合作伙伴关系。Redesign 总部位于纽约，并在 Bengaluru、Los Angeles 和 Riyadh 设有办公室。关于该职位：大多数医疗健康投资者等待公司主动找上门。这个职位则负责创造公司。Redesign Health 与 Cedars-Sinai 推出了数字创新平台，这是一个首创的风险创建引擎，嵌入全球顶级学术医疗中心之一。该平台将 Redesign 的医疗健康公司构建方法与独立风险投资公司无法提供的资源相结合：Cedars-Sinai 的 4,500 多名医生和护士、其覆盖 40 多家医院和护理站点的广泛临床网络，以及一个专为

⚑ 岗位信息收录自公开招聘页（公开招聘平台），以雇主官网为准